Could Jaguar Health Inc. (JAGX)s Current Volatility Hinder Its Future Potential?
Jaguar Health Inc. (NASDAQ:JAGX) has a beta value of 1.54 and has seen 12.71 million shares traded in the last trading session. The company, currently valued at $245.82M, closed the last trade at $1.79 per share which meant it lost -$0.12 on the day or -6.28% during that session. The JAGX stock price is -149.72% off its 52-week high price of $4.47 and 89.39% above the 52-week low of $0.19. If we look at the companys 10-day average daily trading volume, we find that it stood at 19.83 million shares traded. The 3-month trading volume is 11.12 million shares. The consensus among analysts is that Jaguar Health Inc. (JAGX) is a Buy stock at the moment, with a recommendation rating of 1.00. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 1 have rated it as a Hold, with 1 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is -$0.03. Jaguar Health Inc. (NASDAQ:JAGX) trade information  Sporting -6.28% in the red in last session, the stock has traded in the red over the last five days, with the highest price hit on Monday, 06/14/21 when the JAGX stock price touched $1.79 or saw a rise of 21.49%. Year-to-date, Jaguar Health Inc. shares have moved 119.63%, while the 5-day performance has seen it change -3.24%. Over the past 30 days, the shares of Jaguar Health Inc. (NASDAQ:JAGX) have changed 54.31%. Short interest in the company has seen 7.69 million shares shorted with days to cover at 0.74. Wall Street analysts have a consensus price target for the stock at $4.50, which means that the shares value could jump 60.22% from current levels. The projected low price target is $4.50 while the price target rests at a high of $4.50. In that case, then, we find that the current price level is -151.4% off the targeted high while a plunge would see the stock gain -151.4% from current levels. Jaguar Health Inc. (JAGX) estimates and forecasts  The companys shares have gained 433.06% over the past 6 months, compared to 16.40% for the industry. Revenue growth from the last financial year stood is estimated to be 154.60%. 1 analysts offering their estimates for the company have set an average revenue estimate of $7.28 million for the current quarter. 1 have an estimated revenue figure of $2.44 million for the next quarter concluding in Sep 2021. Year-ago sales stood $3.16 million and $2.77 million respectively for this quarter and the next, and analysts expect sales will grow by 130.40% for the current quarter and -12.00% for the next. Earnings growth for 2021 is a modest 88.90% while over the next 5 years, the companys earnings are expected to increase by 40.00%. 5 Stocks Under $10 That Are Poised to Take Off Investing in stocks under $10 could significantly increase the returns on your portfolio, especially if you pick the right stocks! Within this report you will find 5 top stocks that offer investors huge upside potential and the best bang for their buck. Investing in stocks under $10 could significantly increase the returns on your portfolio, especially if you pick the right stocks! Within this report you will find 5 top stocks that offer investors huge upside potential and the best bang for their buck. Add them to your watchlist before they take off! Get the Top 5 Stocks Now! Sponsored  JAGX Dividends  Jaguar Health Inc. is expected to release its next earnings report in July this year, and investors are excited at the prospect of better dividends despite the companys debt issue. Jaguar Health Inc. (NASDAQ:JAGX)s Major holders  Insiders own 9.90% of the company shares, while shares held by institutions stand at 11.49% with a share float percentage of 12.75%. Investors are also buoyed by the number of investors in a company, with Jaguar Health Inc. having a total of 51 institutions that hold shares in the company. The top two institutional holders are Baillie Gifford and Company with over 2.03 million shares worth more than $3.66 million. As of Mar 30, 2021, Baillie Gifford and Company held 1.48% of shares outstanding. The other major institutional holder is Vanguard Group, Inc. (The), with the holding of over 1.88 million shares as of Mar 30, 2021. The firms total holdings are worth over $3.39 million and represent 1.37% of shares outstanding. Also the top two Mutual Funds that are holding companys shares are Vanguard Extended Market Index Fund and Principal U.S. Small Cap Multi Factor Index ETF. As of Mar 30, 2021, the former fund manager holds about 1.33% shares in the company for having 1.82 million shares of worth $3.28 million while later fund manager owns 1.16 million shares of worth $1.85 million as of May 30, 2021, which makes it owner of about 0.84% of companys outstanding stock.